Skip to main content
. 2013 Nov 6;31(1):89–100. doi: 10.1007/s10815-013-0127-6

Table 1.

Study eligibility criteria

Target population Infertile patients undergoing intrauterine insemination
Intervention Luteal phase support with progesterone versus a control group
Outcome measure One or more of the following (per patient or per cycle)
 • Live birth (per cycle analysed)
 • Ongoing pregnancy (per cycle analysed)
 • Clinical pregnancy (per cycle analysed)
 • Preclinical pregnancy or biochemical pregnancy (per cycle analysed)
 • Biochemical loss (per cycle analysed)
 • Miscarriage (per cycle analysed)
 • Multiple pregnancy (per cycle analysed)
Design Randomized controlled trial